| Accession Number: | 0001209191-21-060364 |
| Date: | 2021-10-11 |
| Issuer: | NGM BIOPHARMACEUTICALS INC (NGM) |
| Original Submission Date: |
CHEN JIN-LONG
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-10-11 | S | 15,000 | d | $20.41 | 914,449 | direct | ||
| COMMON STOCK | 2021-10-12 | S | 15,000 | d | $20.14 | 899,449 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on july 6, 2021. |
| f2 | represents a weighted average sales price per share. these shares were sold in multiple transactions at prices ranging from $19.75 to $20.66. the reporting person has provided to the issuer, and undertakes to provide to the staff of the commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| f3 | represents a weighted average sales price per share. these shares were sold in multiple transactions at prices ranging from $19.91 to $20.52. the reporting person has provided to the issuer, and undertakes to provide to the staff of the commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
